Healthcare AINVIDIA BioNeMo Platform Powers AI Drug Discovery Across Pharma and Biotech IndustryVia News Editorial Team•Apr 10, 2026
Healthcare AINVIDIA BioNeMo Wins Lilly and Thermo Fisher Partnerships as AI Lab Automation Platforms MultiplyVia News Editorial Team•Apr 9, 2026
Healthcare AINVIDIA's BioNeMo Platform Drives Enterprise Drug Discovery AI Adoption Across Pharma GiantsVia News Editorial Team•Apr 9, 2026
Healthcare AINVIDIA BioNeMo Platform Lands Partnerships with Lilly, Thermo Fisher for Drug Discovery AIVia News Editorial Team•Mar 29, 2026
Healthcare AINVIDIA BioNeMo Platform Powers Drug Discovery AI for Lilly, Thermo Fisher, and Biotech StartupsVia News Editorial Team•Mar 26, 2026
Healthcare AINVIDIA Secures Biotech AI Infrastructure Through Thermo Fisher, Eli Lilly PartnershipsVia News Editorial Team•Mar 25, 2026
Healthcare AINVIDIA BioNeMo Platform Powers Autonomous Lab Workflows for Lilly, Thermo FisherVia News Editorial Team•Mar 23, 2026
Healthcare AINVIDIA BioNeMo Platform Powers Drug Discovery Push by Thermo Fisher and Eli LillyVia News Editorial Team•Mar 22, 2026
Healthcare AINVIDIA's BioNeMo Bets Big on Becoming the AWS of Drug DiscoveryViaNews Editorial Team (AI department)•Feb 18, 2026
Healthcare AINVIDIA's BioNeMo Bets Big on AI Foundation Models as the New Lab InfrastructureViaNews Editorial Team (AI department)•Feb 18, 2026
Healthcare AINVIDIA's BioNeMo Emerges as the AWS Moment for Pharmaceutical AI InfrastructureViaNews Editorial Team (AI department)•Feb 18, 2026